350 related articles for article (PubMed ID: 33465452)
1. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
[TBL] [Abstract][Full Text] [Related]
2. Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.
Wu R; Lyons JJ
Curr Allergy Asthma Rep; 2021 May; 21(5):33. PubMed ID: 33970354
[TBL] [Abstract][Full Text] [Related]
3. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G
Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817
[TBL] [Abstract][Full Text] [Related]
4. The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia.
Luskin KT; White AA; Lyons JJ
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2235-2242. PubMed ID: 33744473
[TBL] [Abstract][Full Text] [Related]
5. Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1.
Lyons JJ; Chovanec J; O'Connell MP; Liu Y; Šelb J; Zanotti R; Bai Y; Kim J; Le QT; DiMaggio T; Schwartz LB; Komarow HD; Rijavec M; Carter MC; Milner JD; Bonadonna P; Metcalfe DD; Korošec P
J Allergy Clin Immunol; 2021 Feb; 147(2):622-632. PubMed ID: 32717252
[TBL] [Abstract][Full Text] [Related]
6. Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions.
Lyons JJ; Greiner G; Hoermann G; Metcalfe DD
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1964-1973. PubMed ID: 35597543
[TBL] [Abstract][Full Text] [Related]
7. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone.
Šelb J; Rijavec M; Eržen R; Zidarn M; Kopač P; Škerget M; Bajrović N; Luzar AD; Park YH; Liu Y; Šerbec VČ; Zver S; Košnik M; Lyons JJ; Korošec P
J Allergy Clin Immunol; 2021 Aug; 148(2):621-626.e7. PubMed ID: 33753098
[TBL] [Abstract][Full Text] [Related]
8. Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia.
Konnikova L; Robinson TO; Owings AH; Shirley JF; Davis E; Tang Y; Wall S; Li J; Hasan MH; Gharaibeh RZ; Mendoza Alvarez LB; Ryan LK; Doty A; Chovanec JF; O'Connell MP; Grunes DE; Daley WP; Mayer E; Chang L; Liu J; Snapper SB; Milner JD; Glover SC; Lyons JJ
J Allergy Clin Immunol; 2021 Sep; 148(3):813-821.e7. PubMed ID: 33865872
[TBL] [Abstract][Full Text] [Related]
9. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.
Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.
Glover SC; Carter MC; Korošec P; Bonadonna P; Schwartz LB; Milner JD; Caughey GH; Metcalfe DD; Lyons JJ
Ann Allergy Asthma Immunol; 2021 Dec; 127(6):638-647. PubMed ID: 34400315
[TBL] [Abstract][Full Text] [Related]
11. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology.
Giannetti MP; Akin C; Hufdhi R; Hamilton MJ; Weller E; van Anrooij B; Lyons JJ; Hornick JL; Pinkus G; Castells M; Pozdnyakova O
J Allergy Clin Immunol; 2021 Apr; 147(4):1497-1501.e1. PubMed ID: 33248113
[TBL] [Abstract][Full Text] [Related]
12. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions.
Shin H; Lyons JJ
Curr Allergy Asthma Rep; 2024 Apr; 24(4):199-209. PubMed ID: 38460022
[TBL] [Abstract][Full Text] [Related]
13. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
Kačar M; Rijavec M; Šelb J; Korošec P
Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
[TBL] [Abstract][Full Text] [Related]
14. Defining hereditary alpha-tryptasemia as a risk/modifying factor for anaphylaxis: are we there yet?
Couto ML; Silva M; Barbosa MJ; Ferreira F; Fragoso AS; Azenha Rama T
Eur Ann Allergy Clin Immunol; 2023 Jul; 55(4):152-160. PubMed ID: 36927821
[TBL] [Abstract][Full Text] [Related]
15. Clinical response to omalizumab in patients with hereditary α-tryptasemia.
Mendoza Alvarez LB; Barker R; Nelson C; DiMaggio T; Stone KD; Milner JD; Rosenthal JA; Petroni DH; Glover SC; Lyons JJ
Ann Allergy Asthma Immunol; 2020 Jan; 124(1):99-100.e1. PubMed ID: 31605754
[No Abstract] [Full Text] [Related]
16. Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome.
Hamilton MJ; Zhao M; Giannetti MP; Weller E; Hufdhi R; Novak P; Mendoza-Alvarez LB; Hornick J; Lyons JJ; Glover SC; Castells MC; Pozdnyakova O
Am J Surg Pathol; 2021 Jul; 45(7):997-1004. PubMed ID: 33481382
[TBL] [Abstract][Full Text] [Related]
17. Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis.
Mateja A; Wang Q; Chovanec J; Kim J; Wilson KJ; Schwartz LB; Glover SC; Carter MC; Metcalfe DD; Brittain E; Lyons JJ
J Allergy Clin Immunol; 2022 Mar; 149(3):1010-1017.e10. PubMed ID: 34425177
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of the TPSAB1 genotype in mast cell diseases: A REMA study in a cohort of 959 individuals.
González-de-Olano D; Navarro-Navarro P; Muñoz-González JI; Sánchez-Muñoz L; Henriques A; de-Andrés-Martín A; Peralta-Arjonilla D; Mayado A; Jara-Acevedo M; García-Montero AC; Orfao A; Álvarez-Twose I
Allergy; 2024 Mar; 79(3):711-723. PubMed ID: 37818990
[TBL] [Abstract][Full Text] [Related]
19. Pediatric Expression of Mast Cell Activation Disorders.
Broesby-Olsen S; Carter M; Kjaer HF; Mortz CG; Møller MB; Kristensen TK; Bindslev-Jensen C; Agertoft L
Immunol Allergy Clin North Am; 2018 Aug; 38(3):365-377. PubMed ID: 30007457
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes.
Polivka L; Madrange M; Bulai-Livideanu C; Barete S; Ballul T; Neuraz A; Greco C; Agopian J; Brenet F; Dubreuil P; Burdet C; Lemal R; Tournilhac O; Terriou L; Launay D; Bouillet L; Gourguechon C; Damaj G; Frenzel L; Meni C; Bouktit H; Collange AF; Gaudy-Marqueste C; Gousseff M; Le Mouel E; Hamidou M; Neel A; Ranta D; Jaussaud R; Guilpain P; Canioni D; Molina TJ; Bruneau J; Lhermitte L; Garcelon N; Javier RM; Pelletier F; Castelain F; Retornaz F; Cabrera Q; Zunic P; Gourin MP; Wierzbicka-Hainaut E; Viallard JF; Lavigne C; Hoarau C; Durieu I; Heiblig M; Dimicoli-Salazar S; Torregrosa-Diaz JM; Soria A; Arock M; Lortholary O; Bodemer C; Hermine O; Rossignol J;
J Allergy Clin Immunol; 2024 Jan; 153(1):349-353.e4. PubMed ID: 37633651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
